Personal care products (PCP) contain a myriad of chemicals generally formulated to provide a safe and beneficial use. Nonetheless, an increasing amount of laboratory animal and human studies indicate that some chemicals in PCP are associated with decreased hormone production, diminished ovarian reserve, ovarian cancer, and early pregnancy loss. The ovary is key to female fertility by providing the eggs and sex steroid hormones for fertilization and maintenance of reproductive function, respectively. Thus, understanding how chemicals in PCP affect the ovary will shed some light on their potential effects on female fertility. In this review, we provide an overview of: (1) ovarian function as a determinant of fertility in females, (2) the status of knowledge regarding the effects of seven common chemicals in PCP on the ovary, and (3) significant gaps in the literature along with opportunities to eliminate some of the gaps. Findings from the limited existing data suggest that chemicals in PCP such as dibutyl phthalate can reach the ovary in humans and impact its function in animal models. Unfortunately, it is still difficult to assess how relevant findings of experimental studies are to women because of lack of human exposure data for most of these chemicals and the lack of studies that mimic real-life exposures. In contrast to chemicals such as bisphenol A and dioxin, the investigation of the effects of chemicals in PCP on reproductive function is still limited and warrants further investigation to fill existing data gaps.
Personal care products (PCP) including cosmetics are generally used for improving health, attractiveness, and overall selfesteem. The decision of which PCP to use is likely to be based on a number of reasons including lifestyle, socioeconomic status, trends, and health outcomes. However, the disclosure of compounds in PCP is frequently incomplete and may not be easily interpreted as a potential health risk by the consumer. Research on potential harmful effects of some of the chemicals in PCP is extremely limited and mainly focused on high doses. This is concerning because some chemicals in PCP may act as endocrine disruptors (Chow and Mahalingaiah, 2016) and, like physiological hormones, be biologically active at low serum concentrations. Moreover, because PCP are used on a daily basis, it is reasonable to infer that these passive lifestyle exposures to chemicals in PCP add to the overall burden of environmental exposures.
Women have been shown to have a greater burden of PCP chemicals in their bodies when compared with men (Biesterbos et al., 2013) and thus, are considered a susceptible population. Cosmetologists and hair dressers are an extreme example of exposure to some of these chemicals. A recent meta-analysis reported an increased risk of infertility in cosmetologists compared with noncosmetologists (Henrotin et al., 2015) . Yet, there is a large gap in knowledge regarding which chemicals in PCP can affect female's reproduction and through which mechanisms they do so. The ovary is key to female fertility due to its role in the production and maturation of eggs and the synthesis of the female sex steroid hormones that regulate reproductive function. Therefore, in this review we (1) provide an overview of ovarian function as a determinant of fertility, (2) summarize the status of the literature on the effects of seven major chemicals in PCP on reproductive function with an emphasis on the ovary, and (3) conclude by noting significant gaps in knowledge and areas of research we propose to move the field forward.
THE OVARY AND ITS ROLE IN ENSURING FEMALE FERTILITY
The ovary is the main endocrine organ in the female that is important for both proper physiological function and the ability to reproduce. In humans, ovarian development is completed during embryonic life and in rodents it is completed around postnatal day (PND) 8. During this time, a finite pool of resting oocytes enclosed within ovarian follicles is established and represents the ovarian reserve. Also at this time, the oocytes remain in the diplotene stage of late prophase. At puberty, neuroendocrine signals initiate the ovarian cycle in which the oocytes undergo meiotic division (meiosis I) and the process of follicle recruitment and development (ie, folliculogenesis) is initiated. From that point, the ovary contains follicles at different developmental stages (ie, primordial, primary, preantral, and antral) that continuously develop until the ovarian reserve is exhausted and the female enters to reproductive senescence (menopause in women). Ovarian development and function depend on highly coordinated biological processes (Edson et al., 2009) . Disruptions of these processes can lead to impaired reproductive function such as loss of pregnancy, infertility (temporal or permanent), and premature ovarian failure. Environmental exposures can exhaust the follicle pool and lead to premature ovarian failure and permanent infertility (Figure 1 ) (Vabre et al., 2017) .
The most mature form of ovarian follicles (ie, antral follicles) are the main functional units within the ovary as they are able to ovulate the oocyte for fertilization. The ovulated follicle turns into an endocrine structure termed corpus luteum that will either support early stages of pregnancy or will eventually degenerate. Fertilized oocyte completes the second meiotic division (meiosis II) and will be implanted in the uterus. From this stage, embryonic development will ensue until birth. The number of corpora lutea, embryo implantation sites, and birth outcomes (eg, number of offspring, sex ratio) are commonly used as biomarkers of reproductive function in laboratory animal studies. The antral follicles are also the main source of sex steroid hormones synthesized by the ovary. Steroidogenesis is a multistep enzymatic process that occurs in the follicular cells (theca and granulosa cells). Cholesterol, the precursor of steroidogenesis, is predominantly converted to progesterone, testosterone, and estradiol. These hormones are crucial for both ovarian function, pregnancy maintenance, and overall physiological function (eg, bone health, brain, and cardiovascular system). Hence, ovotoxicity can cause altered hormone levels and an impaired ability to ovulate a healthy oocyte leading to decreased reproductive capacity, and impaired physiological function (Crain et al., 2008) .
EFFECTS OF CHEMICALS IN PCP ON REPRODUCTIVE FUNCTIONS
Of the many chemicals in PCP, here we focus on dibutyl phthalates, parabens, triclosan, talc, butylated hydroxytoluene (BHT), formaldehyde, and polyethylene glycols (PEGs). These were identified as chemicals of concern by nonprofit environmental groups and governmental agencies (Alyaka, 2017; Cunningham, 2014; Freije, 2017; EWG's Deep Skin Cosmetics Database) and are prevalently found in many PCP. These chemicals were also selected based on documented effects on ovarian function and/ or epidemiological data linking them to an adverse reproductive outcome in women. We describe findings from epidemiological studies (Table 1) , animal studies (Table 2) , and mechanistic Figure 1 . The mammalian ovary contains follicles at different developmental stages (ie, primordial, primary, preantral, and antral) that continuously develop until the ovarian reserve is exhausted, and the female enters to reproductive senescence. The effects on reproductive capacity depend on the type of follicle/ovarian structure that is impacted. Toxicity of early follicular structures (primordial and primary) can cause infertility unless exposure is halted. Acute toxicity of preantral and antral follicles can alter steroidogenesis and block ovulation. Acute toxicity of the corpus luteum can alter steroidogenesis and the ability to maintain early stages of pregnancy. Long term exposures can also cause depletion of other types of follicle types as they are recruited to replace lost mature follicles, thus leading to permanent infertility. studies (Table 3) on the mammalian ovary while providing potential mechanisms of action in the context of hormonal influences and molecular targets. We conclude with emphasizing gaps in knowledge and future directions. Overall the field of chemicals in PCP and ovotoxicity is underdeveloped and warrant additional studies.
Dibutyl Phthalate
Both di-n-butyl and di-isobutyl phthalates (DBP) are clear, oily liquids produced by reacting n-butanol with phthalic anhydride. DBP are commonly used as industrial solvents and additives in many consumer products such as printing inks, coated medications, insecticides and, notably, in PCP such as nail polish and cosmetics. DBP use in cosmetics is banned by several countries (eg, the European Union, Australia). The estimated daily intake in humans is 7-10 mg/kg/d in the general population and 233 mg/kg/d in patients taking DBP-coated medications (Hernandez-Diaz et al., 2013) . In humans, about 65%-80% of an oral dose of DBP is eliminated in urine within 24 h, mostly as mono-n-butyl phthalate (MBP) (Centers for Disease and Prevention, 2005) . Additionally, DBP metabolites can reach the ovary and have been measured in the follicular fluid of women undergoing in vitro fertilization (median: 2.05 ng/ml) (Du et al., 2016) .
Epidemiological studies have evaluated potential associations between urinary markers of phthalate exposure, including DBP, and reproductive outcomes in women such as testosterone levels, oocyte yield during in-vitro fertilization, and ovarian reserve Meeker and Ferguson, 2014; Messerlian et al., 2016) . Only decreased serum testosterone has been associated with increased urinary MBP. Animal studies evaluating the effects of DBP and MBP exposure have revealed significant changes in ovarian weights, estradiol levels, and ex vivo ovarian hormone production (500 mg/kg/d), thus, suggesting that the ovary is a target for these phthalates (Kay et al., 2013) . Recently, experiments have demonstrated that DBP is capable of disrupting folliculogenesis and ovarian granulosa and luteal cell physiology at concentrations closer to those estimated in humans. Specifically, DBP (100 mg/kg/d; comparable to medication users) decreased estradiol levels, increased folliclestimulating hormone (FSH) levels, and decreased antral follicle numbers in young adult mice (Sen et al., 2015) . Further, DBP at levels comparable to human follicular fluid (2.8 ng/ml), reduced basal and hCG-stimulated progesterone secretion and reduced secretion of the luteotropic factors PGE 2 and VEGF in human luteal cells (Romani et al., 2014) . Additionally, studies modeling gestational exposure to a mixture of phthalates, including DBP, reported an increased incidence of cystic ovaries in the offspring of treated mice (Zhou et al., 2017a,b) . Lastly, in a multigeneration study, maternal exposure to a mixture of plasticderived chemicals, including DBP, led to low primordial follicle counts and increased number of ovarian cysts in the daughters and granddaughters of treated rats (Manikkam et al., 2013) . These findings suggest that DBP targets both mature ovarian follicles and luteal cells, thus, affecting steroidogenesis, ovulation, and early pregnancy. Yet, most of these experiments examined levels higher than the estimated daily intake levels.
Mechanistic studies have characterized the mode of action for DBP in the ovary using whole ovaries, antral follicles, and isolated ovarian cells. In vitro exposures to DBP on mouse antral Other ovarianrelated Outcomes Dibutyl phthalates LE rats, gavage, weaning through puberty, mating, gestation, and lactation up to day 13 of the second pregnancy. Doses 250-1000 mg/kg/d (Gray et al., 2006) Hemorrhagic corpora lutea (1000)
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" Mid-pregnancy loss (500, 1000) $ Estrous cycle $ Implantation CD-1 mice, oral, 10 days. Doses 0.01-1000 mg/kg/d (Sen et al., 2015) # Antral follicles (0.1) # Corpora lutea (1000) $ Follicle numbers " Primordial follicles (1000) # Early primary follicles $ Ovarian weight
Folliculogenesis " Amh (250, 1000) " Kitl (250, 1000) " Foxl2 (250, 1000) SD, gavage, PND21-40. Doses 62.5-1000 mg/kg/d (Vo et al., 2010) # Corpora lutea (62.5, 1000) " Cystic follicles (62.5, 1000) $ Ovarian weight $ Estradiol $ 4-day estrous cycle $ PRL Methylparaben SD rats, SC, PND1-7. Doses 62.5-1000 mg/kg/d (Ahn et al., 2012) $ Ovarian weight $ Primordial follicles " Primary follicles (250, 1000)
$ Kitl SD rats, gavage, PND21-40. Doses 62.5-1, 000 mg/kg/d (Vo et al., 2010) # Ovarian weight (1, 000) # Corpora lutea (250) " Cystic follicles (250) $ Estradiol " 4-day estrous cycle (1000) $ PRL Propylparaben SD rats, gavage, PND21-40. Doses 62.5-1000 mg/kg/d (Vo et al., 2010) $ Ovarian weight $ Corpora lutea $ Cystic follicles $ Estradiol " 4-day estrous cycle (1000) $ PRL SD rats, SC, PND1-7. Doses 62.5-1000 mg/kg/d (Ahn et al., 2012) " Primordial follicles (1000) # Early primary follicles (250, 1000) $ Ovarian weight $ Ovarian weight follicles found that DBP at levels comparable to human follicular fluid did not cause growth inhibition or follicular death; whereas, higher concentrations of DBP (10 mg/ml) caused antral follicle growth inhibition and significant disruptions in cell cycle gene expression and elicited cell cycle arrest followed by follicular death (Craig et al., 2013; Rasmussen et al., 2017) . In rat granulosa cells and preantral follicles, DBP (5-100 mg/ml) interfered with FSH-stimulated expression of Kitl, reduced the expression of Fshr and downstream factors, and reduced steroidogenesis . Finally, DBP (10 and 100 lg/ml) selectively decreased estradiol and progesterone secretion accompanied by disrupting expression of mRNAs essential for steroidogenesis, angiogenesis, growth factor signaling, and global gene expression (mainly related to cell cycle) in human mural granulosa cells (Adir et al., 2017a,b) . Collectively, available data provide strong evidence for DBP disrupting ovarian function by targeting key pathways such as cell cycle progression, apoptosis, and steroidogenesis.
Nevertheless, linking these findings to human exposures and identifying the molecular mechanisms through which DBP exerts its effects on the ovary still warrant further investigation.
Parabens
Parabens are organic alkyl esters of p-hydroxybenzoic acid used as antimicrobial preservatives in cosmetics, pharmaceuticals, and food products. The most commonly used parabens in cosmetics are methylparaben, butylparaben, and propylparaben. They are generally regarded as safe and approved for use by the U.S. Food and Drug Administration and the European Union (Soni et al., 2001) . However, some countries restrict the maximal combined concentration of parabens in cosmetic products (0.8%w/w) (Routledge et al., 1998) . The highest estimated daily intake of parabens from PCP in adults (averaged weight of 60 kg) is 2.368 mg/kg bw/d (Błe R dzka et al., 2014). (Rasmussen et al., 2017) Follicle growth # 100-1000 mg/ml Follicle viability # 500, 1000 mg/ml Cell cycle regulators " #$ 0.001, 10-1000 mg/ml Apoptotic factors " $ 1, 100, 1000 mg/ml Mouse antral follicles (Craig et al., 2013) Cell cycle regulators "#$ 10-1000 mg/ml Apoptotic factors "# 1000 mg/ml Follicle growth #$ 1000 mg/ml Steroidogenesis #$ 1000 mg/ml Rat granulosa cells Apoptotic factors $ 20, 100 mg/ml
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In women, higher urinary levels of paraben were associated with reduced antral follicle count (Smith et al., 2013) , a shorter length of the menstrual cycle (Nishihama et al., 2016) , and decreased odds of becoming pregnant (Smarr et al., 2017) . Further, paraben levels measured during pregnancy were associated with a decreased ratio of estradiol/progesterone and increased levels of sex hormone binding globulin, indicating that parabens may decrease estradiol availability during pregnancy (Aker et al., 2016 ). Yet, others reported that urinary concentrations of parabens were not associated with in vitro fertilization outcomes including oocyte yield, embryo quality, and fertilization rates (Minguez-Alarcon et al., 2016) These findings inconclusively suggest that parabens may impair the ability of women to get pregnant and potentially affect fetal growth and development. In experimental studies, butylparaben exposure (500 mg/kg/d; gestation through weaning) reduced ovarian weight in the prepubertal rat offspring (Boberg et al., 2016) . However, in utero butylparaben exposure (10-1000 mg/kg/d) did not affect ovarian weight, the number of follicles or corpora lutea, estrous cyclicity, or levels of progesterone and estradiol in rats offspring (Daston, 2004; Guerra et al., 2017) . Differences between these findings suggest that paraben may act during specific developmental windows. In support of that, in utero paraben exposure at high concentrations (62.5-1000 mg/kg/d), during the establishment of ovarian reserve inhibited folliculogenesis and altered expression of steroidogenic enzymes and genes related to folliculogenesis (Star, Cyp11a1, Amh, Kitl, Foxl2) in neonatal rat offspring (Ahn et al., 2012) . Similarly, paraben exposure decreased ovarian weight, decreased the number of corpora lutea, increased number of cystic follicles, thinned the follicular epithelium, altered estrous cycle, and decreased estradiol levels, in young adult rats (Vo et al., 2010) . These studies indicate that parabens can target major ovarian structures and function when administered at specific developmental windows; however, these studies evaluated relatively high concentrations of parabens compared with the estimated daily intake of humans.
Mechanistic studies using ovarian tissues are lacking, but reports using nonovarian cell lines suggest that parabens may act via nuclear receptors and nongenomic pathways that are also found in the ovary. Specifically, parabens can have estrogenic activity and can bind both estrogen receptor (ER) a and ERb, but with lower affinity than estradiol (Routledge et al., 1998; Witorsch and Thomas, 2010) . Additionally, parabens (10 mM) increased expression of the cytosolic calcium-binding protein (CaBP-9k) via a progesterone receptor-mediated pathway, in GH3 cells and can bind human androgen receptor and inhibit testosterone-induced transcription in HEK293 cells (10 lM) (Chen et al., 2007) . Interestingly, parabens at levels similar to those that were measured in human tissues (20 nM) selectively affected nongenomic factors including GPR30, cAMP, and ERK1/2-Akt, in MCF-7 and MCF-10 A cells (Wrobel and Gregoraszczuk, 2015) . Additionally, parabens (20 nM) can selectively affect the expression of the key steroidogenic enzyme aromatase, cell cycle regulators, and apoptotic genes, depending on cell type Gregoraszczuk, 2013, 2014) . Last, paraben (30 mM) increased progesterone, but not estradiol or testosterone synthesis, in H295R cells (Taxvig et al., 2008) ; whereas paraben increased estradiol levels in MCF-7 cells (200 nM) and decreased in MCF-10 A cells (2 mM) (Wrobel and Gregoraszczuk, 2013) .
Collectively, these studies suggest that parabens may affect the ovary during specific developmental windows by modulation of endocrine and basic cellular functions, in a cell and concentration-specific manner. Yet, similar to DBP, there are no data regarding paraben effects and molecular targets in ovarian follicles or the oocyte in particular. Potential multigenerational effects and the effects of parabens in a mixture of chemicals are also unidentified.
Triclosan
Triclosan is an organic, lipid-soluble halogenated biphenyl ether that has antibacterial and antifungal properties. Its chemical structure is similar to other endocrine disrupting chemicals such as polychlorinated biphenyls and bisphenol A and has dioxin-like photoproducts (Anger et al., 2013) . It is found in various products including antibacterial soaps/detergents, toothpastes, and creams (Dhillon et al., 2015; Fang et al., 2010; Wang and Tian, 2015; Yueh and Tukey, 2016) . In recent years, the use of triclosan in PCP has been banned in various countries (Dhillon et al., 2015) . The U.S. Environmental Protection Agency considers triclosan as a pesticide and the U.S. FDA has recently prohibited the marketing of antiseptic wash products containing triclosan (Food and Drug Adminnistration, HHS, 2016) . The range of human daily exposure is 0.047-0.073 mg/kg/d (Rodricks et al., 2010) . Cell viability " # $ 5-100, 500 mg/ml Neoplastic transformation " 0.5-500 mg/ml Reactive oxygen species " # 0.5-500 mg/ml BHT Rat oocyte cumulus complexes (Takami et al., 1999) Germinal vesicle breakdown # 100 mM
Rat luteal cells (Carlson et al., 1995) Steroidogenesis " 23-57 mM CHO cell-line (Grillo and Dulout, 2006; Grillo and Dulout, 1995) Chromatid and chromosome breaks " 0.1-0.5 mg/ml
Sister chromatid exchanges $ 0.5 mg/ml Cells in second division # 0.5 mg/ml Cytotoxicity "
Arrows represent overall effect compared with controls: " increase, # decrease, or $ no difference compared with control.
In women undergoing fertility treatments, higher urinary triclosan concentrations were associated with higher baseline antral follicle counts, number of oocytes retrieved, number of mature (MII-stage) oocytes, and higher peak estradiol levels (Hua et al., 2017) . Despite these somewhat favorable outcomes, higher urinary triclosan concentrations were associated with lower fertilization and implantation rates, but with a null association with pregnancy rate (Hua et al., 2017) . Moreover, triclosan association with fecundability is inconsistent (M ınguez-Alarc on et al., 2017; Smarr et al., 2017; Velez et al., 2015) . Last, higher urinary triclosan concentrations were associated with an increased risk of mid-gestational spontaneous abortion . These findings suggest that triclosan may affect the ability to get pregnant and to maintain pregnancy to term; however, its mechanism of action is unknown. Experimental studies are also inconclusive. Prolonged exposure (125 mg/kg/d) of triclosan decreased ovarian weights, in mice (Fang et al., 2015) ; whereas shorter exposure (0.4 mg/l or 150 mg/l) did not affect ovarian weights, in rats (Stoker et al., 2010; Yang et al., 2015) . Moreover, triclosan (30-600 mg/kg/d) decreased serum levels of progesterone, estradiol, testosterone, and prolactin in pregnant rats (Feng et al., 2016) ; Similarly, triclosan (37.5-150 mg/l) decreased estradiol levels in prepubertal rats (Stoker et al., 2010) ; whereas, a single dose (71.0 6 3.7 mg/kg) did not affect estradiol levels in adult mice (Pollock et al., 2016) . These limited findings suggest that triclosan at high levels may target the ovary and affect ovarian steroidogenesis, depending on the study design and species.
Cell-based experiments indicated that triclosan has antiandrogenic, antiestrogenic and estrogenic effects (Chen et al., 2007; Gee et al., 2008; Wang and Tian, 2015; Witorsch and Thomas, 2010) . Triclosan has a higher binding affinity to ERa over ERb (Crawford and Decatanzaro, 2012; Gee et al., 2008; Jung et al., 2012; Louis et al., 2013) . Triclosan promoted cell proliferation and altered expression of ERa and ERa-specific microRNAs (mir-22 and mir-193 b) , in MCF-7 cells (Huang et al., 2014) . Similarly, triclosan increased proliferation of BG-1 cells via an ER-dependent signaling pathway, while altering mRNAs of cell cycle regulators (cyclin D1 and p21) and the apoptotic factor Bax (Kim et al., 2014) . In several experimental modalities, triclosan enhanced the estrogenic effects of ethinyl estradiol (Louis et al., 2013) . Further, triclosan may interfere with xenobiotic metabolizing processes because it causes weak agonistic and/or antagonistic activity in aryl hydrocarbon receptorresponsive cell bioassay (Ahn et al., 2008) . Similarly, triclosan is an agonist for human pregnane X receptor (HuH7 cells) and human constitutive androstane receptor (Jacobs et al., 2005; Yueh et al., 2014; Yueh and Tukey, 2016) . These findings indicate that triclosan can act as a xenoestrogen via several signaling pathways; however, these effects were evaluated in relatively high levels compared with the average daily human exposure and were not evaluated in ovarian tissue.
Overall, limited findings suggest that triclosan affects ovarian function. Potential mechanisms of action include signaling pathways that involve nuclear receptors, regulators of drug metabolizing, cell cycle, apoptosis, and steroidogenesis. Yet, additional studies are needed to confirm these molecular targets in the ovary. Lastly, similar to the other chemicals described above, developmental effects, transgenerational effects, and direct effects of triclosan on the oocyte, in physiological concentrations have not been evaluated, yet.
Talc
Talc is an inorganic layered magnesium silicate used in cosmetics mainly as an abrasive, absorbent, skin protectant, and anticaking agent (Fiume et al., 2015) . It can be found in thousands of formulations (eg, makeup, lotions, bath products, and various types of sprays) at maximum concentrations of use ranging from 0.0005% to 100% (Fiume et al., 2015) . It is restricted in the European Union (Fiume et al., 2015) . Though talc was measured in normal and cancerous ovarian tissue (Fiume et al., 2015) , only a few studies have examined talc exposure and ovotoxicity. Epidemiological studies reported an increased risk of epithelial ovarian cancer for women who use genital talc, with a greater risk for women carrying specific genetic variants related to metabolism of carcinogens and reactive oxygen species (Cramer et al., 1982 (Cramer et al., , 2016 Fiume et al., 2015; Gates et al., 2008; Vitonis et al., 2011) . However, other studies also reported no association between talc use and ovarian cancer (reviewed in Fiume et al., 2015) . In animal models, intrabursal injection of talc (100 mg/ml) did not affect levels of steroid hormones but resulted in cystic ovaries (Hamilton et al., 1984) . Additionally, intravaginal or perineal exposure to talc for 3 months resulted in a higher occurrence of ovarian infection (Keskin et al., 2009) . Last, talc selectively increased cell viability, neoplastic transformation, and cellular levels of reactive oxygen species in cultures of human ovarian stromal (GC1a) and epithelial (OSE2a) cells (Buz'Zard and Lau, 2007) . Overall, some studies suggest a potential link between ovarian cancer and talc exposure in both epidemiological and experimental models. However, more studies are needed to confirm these findings and to better understand the levels, timing of exposure, and genetic backgrounds that may be associated with a greater risk. Last, the effects of talc on ovarian steroidogenesis, folliculogenesis, and the oocyte are unknown.
Butylated Hydroxytoluene
BHT is an organic lipophilic compound, derivative of phenol with the ability to react with many reactive oxygen species (Lanigan and Yamarik, 2002) . In cosmetics such as lipsticks, moisturizers, and creams, it is used as a preservative. Its maximum concentrations of use in cosmetics mostly range between 0.0002% and 0.5% (Lanigan and Yamarik, 2002) and the estimated human daily intake is 0.2 mg/kg bw (NIOSH). Currently, there are no epidemiological studies that investigated the association between BHT and fertility in women. Only 1 study examined the effects of continuous BHT (25-500 mg/kg/d) exposure of rats and reported no effect on number of resorption sites (McFarlane et al., 1997) . In contrast, in vitro studies provide some evidence that BHT is an ovarian toxicant. In cultures of rat oocyte cumulus complexes, BHT (100 mM) significantly inhibited spontaneous oocyte maturation, indicating that BHT can inhibit spontaneous resumption of meiosis and impair oocyte development (Takami et al., 1999) . BHT (23-57 mM) increased in vitro luteal progesterone synthesis, by potentially modulating the enzymatic activity of P450 side-chain cleavage (a rate-limiting enzyme in steroidogenesis) (Carlson et al., 1995) . Last, BHT (1-10 mg/ml) increased the number of CHO cells with cellular abnormalities (eg, fragmentation, polycentric, polyploidy); while BHT (20 mg/ml) caused 100% cell death (Grillo and Dulout, 1995 , 2006 Patterson et al., 1987) . These findings suggest that BHT can directly target the oocyte. Yet, additional studies are needed to elucidate its mechanism of action and to expand these findings to models relevant to human exposure (that has not been assessed yet) and in vivo models. Further, the effects of BHT on the ovary in a mixture of chemicals including other phenolic compounds have not been investigated.
Formaldehyde Solution
Formaldehyde is most commonly used in cosmetics in an aqueous solution (ie, formalin). It is used in cosmetics as a preservative, biocide, and denaturant. Formaldehyde can be found mainly in hair products and nail hardeners (Boyer et al., 2013) . Generally, the use should not exceed 0.2% in cosmetics and a maximum concentration of 5% in nail hardeners of free formaldehyde (Boyer et al., 2013) . Importantly, formaldehyde can also be formed naturally in the body as a metabolic intermediate. Several countries (eg, Canada, Australia, China) and regional groupings have limited the use of formaldehyde in PCP and prohibited for use in aerosol dispensers (Boyer et al., 2013) . It is also considered a carcinogen by the International Agency for Research on Cancer. The current literature on formaldehyde and the ovary is extremely limited. Epidemiological studies reported increased odds of spontaneous abortion among users of formaldehyde-based disinfectants (John et al., 1994) . Similarly, exposure among woodworkers was associated with delayed conception and spontaneous abortion (Taskinen et al., 1999) . Experimental studies indicate that formaldehyde exposure decreased weight gain of pregnant rats, but had no effect on the number of implantations, resorptions, or corpora lutea (Martin, 1990; Saillenfait et al., 1989) . Though there is a general reduction in the use of formaldehyde in PCP, it is unknown if formaldehyde can reach the ovary and what are its potential toxic effects.
Polyethylene Glycols
PEG are polymers of ethylene glycol/oxide alcohol. In cosmetics, they are used as cream bases in their original form or in combination with their derivatives (CIR, 2004) and can also be found in toothpastes and lipsticks. PEG are used as thickeners, opacifying agents, moisture preserves, fragrance ingredients, and emulsifiers (Jang et al., 2015) . For example, triethylene glycol (TEG) maximum concentration in skin-cleansing products is 0.08% and <2% in perfumes (CIR, 2006) . PEG-4 maximum concentration in nail care products is 20% (CIR, 2006) . Only a small number of experimental studies have examined their potential effects on the ovary. Specifically, TEG exposure had no effect on the number of corpora lutea, or implantations sites, in pregnant mice (CIR, 2006) . In utero TEG exposure did not cause maternal toxicity or abortions over 2 generations, in rats (Bossert et al., 1992; CIR, 2006) . Interestingly, b-sitosterol that has a structural similarity to cholesterol, increased uterine weight and vaginal cornification, indicating its estrogenic properties (CIR, 2004) . Overall, no epidemiological studies investigated the associations between PEG levels and female reproductive function. Additionally, the extremely limited number of experimental studies mainly examined the effects of TEG exposure during pregnancy. These exposures were followed up with only 1 study that examined the effects on the offspring over 2 generations, yet additional studies are needed. Last, there are no mechanistic studies that examined potential ovarian targets and in particular the oocyte.
CONCLUSIONS AND FUTURE DIRECTIONS
Women are continuously exposed to chemicals in PCP. Yet, in contrast to other environmental chemicals (eg, bisphenol A, dioxin) the investigation of their effects on reproductive function is still in its infancy. Findings from the limited available data suggest that some ingredients in PCP (eg, DBP) can reach the ovary in humans and impact its function in animal models. Unfortunately, it is still difficult to assess how relevant findings of many of the available experimental studies are to women.
First, human exposure levels are unknown for most of the chemicals in PCP. In the few studies currently available, urinary levels have not been used to derive estimated daily intakes. Daily intake estimates for humans would allow for the design of more relevant and impactful descriptive and mechanistic studies using animal models. Furthermore, there is a paucity of information regarding the levels of these chemicals in reproductive tissues, which would enhance the design of in vitro mechanistic experiments. A great opportunity to eliminate these gaps in the literature exists in leveraging existing cohorts of women and forming large collaborative teams to measure these chemicals in existing samples, derive daily intakes from these data, and, evaluate associations between these exposures and reproductive health outcomes.
Second, most published studies have mainly examined single chemicals rather than mixtures of chemicals, acute exposures instead of continuous exposures, and relatively high doses. Opportunities to remove these gaps in knowledge exist in the development of research studies that characterize both single and mixtures as well as low and high exposure levels side-by-side. Additionally, thorough testing of developmental windows and offspring over multiple generations as well as characterization of acute versus chronic exposures will significantly impact the ability to better assess the risks associated with these chemicals.
Finally, the molecular mechanisms by which chemicals in PCP target the ovary are yet to be discovered. The few studies currently available have established ovarian follicle growth, follicle death, and steroidogenesis as potential targets for chemicals in PCP. Unfortunately, most of our knowledge has been derived from descriptive studies or in vitro nonovarian cell lines. Although, most molecular pathways investigated have been obvious extensions from the findings of in vivo animal studies, these have been limited to measuring levels of follicle-related growth factors, steroidogenic enzyme expression, and nuclear receptor-binding assays. In this respect, studies aimed at establishing how these chemicals interact with regulatory networks in charge of controlling the ovarian transcriptome and proteome will likely advance this aspect of the field. Lastly, ovarian metabolism is likely to play a pivotal role in modulating the toxic effects of different chemicals. However, no studies to date have specifically explored the role of xenobiotic biotransformation and drug transporters (eg, multidrug resistance transporters) as potential mediators of the ovotoxic effects of chemicals in PCP. Therefore, we propose that studies in this area could greatly impact the field of ovarian toxicology.
